Upstart Impacts Launches Women’s Health Innovation Program
The Philadelphia-based nonprofit is seeking startups to address persistent gender-based gaps in medical research.
Updated on Oct. 15, 2026 in Women’s Health
Live Poll
Should healthcare startups be required to tailor their medical products for both female and male biology?
Philadelphia nonprofit Upstart Impacts has launched a new innovation program designed to help early-stage life sciences and medtech companies improve women's health outcomes. The program provides mentorship and funding introductions to 10 selected startups at no cost and with no equity requirements.
Why it matters
The initiative aims to address systemic healthcare inequities, such as the fact that women are twice as likely to suffer adverse drug effects and 50% more likely to be misdiagnosed after a heart attack. Currently, women's health receives only about 5% of global healthcare research and development funding.
Women are twice as likely to experience adverse effects from drugs as men and are 50% more likely to be misdiagnosed following a heart attack. Currently, women's health initiatives receive only 5% of all global healthcare R&D funding.
The players
Upstart Impacts
Upstart Impacts is a Philadelphia-based nonprofit organization dedicated to accelerating growth for early-stage life sciences and medtech companies.
The details
Selected companies receive access to expert mentorship and networking opportunities to help incorporate female biology into product development. The curriculum is designed to help startups secure capital, building on the success of a 2025 program where 10 participating companies collectively raised $7.4 million.
Timeline
The application process opened on October 15, 2026.
The application window closes on December 15, 2026.
Cohort selections will be announced in January 2027.
The innovation program is scheduled to begin in February 2027.
Health Landscape
The new initiative follows the performance pattern set by the 2025 Upstart Impacts program, which helped 10 companies raise $7.4 million. By targeting early-stage startups, the organization seeks to bridge the significant funding gap that persists within global medical research.
The program aims to develop medical products that better account for female biology, potentially reducing the frequency of misdiagnoses for women in the future. By supporting startups that focus on gender-specific health, the initiative could lead to more effective treatment options for female patients.
The takeaway
Innovation programs often act as a critical bridge for startups needing the mentorship required to secure venture capital. Applicants should focus their proposals on how their technology directly integrates female biology to address documented clinical gaps.
What happens next
The application window for the program closes on December 15, 2026, followed by the announcement of selected startups in January 2027.
Further reading
For more on industry efforts to improve care, visit Philadelphia Women’s Health.
More information
Review eligibility requirements and submit your startup via the women's health innovation program application.
Source note: This article includes information reported by The Manila times.
Live Poll
Should healthcare startups be required to tailor their medical products for both female and male biology?
